Oral Cancer

When you come to us for diagnosis or treatment for oral cancer, our multidisciplinary team of specialists works quickly to create a customized treatment plan that meets your needs. Our surgeons, periodontists, oncologists, and speech and swallowing therapists collaborate to provide comprehensive, compassionate care throughout treatment and recovery. Also, you may be eligible to participate in clinical trials, which offer new treatment approaches to oral cancer and oral precancerous growths.

Clinical Trials and Research Studies

Phase 1

A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety Tolerability Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors (AbbVie M19-345)

Learn More

Phase 2

A PHASE 2 STUDY OF ALKS 4230 IN COMBINATION WITH ANTI-PD-1 (PEMBROLIZUMAB) IN PATIENTS WITH ADVANCED OR RECURRENT HEAD AND NECK SQUAMOUS CELL CANCER CURRENTLY ON TREATENT WITH ANTI-PD-(L)1 WITHOUT HAVING ACHIEVED A COMPLETE REMISSION

Learn More

Phase 1

A Phase 1 Open Label Multi-Arm Multicenter Study of MK-4830 as Monotherapy and in Combination with Pembrolizumab for Participants with Advanced Solid Tumors

Learn More

Phase 6

Site for Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Learn More